Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
YPEG-Somatropin by Xiamen Amoytop Biotech for Turner Syndrome: Likelihood of Approval
YPEG-Somatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Turner Syndrome. According to GlobalData,...
YPEG-Somatropin by Xiamen Amoytop Biotech for Born Small For Gestational Age (SGA): Likelihood of Approval
YPEG-Somatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Born Small For Gestational Age...
YPEG-Somatropin by Xiamen Amoytop Biotech for Idiopathic Short Stature: Likelihood of Approval
YPEG-Somatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Idiopathic Short Stature. According to...